| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
3 companies
Pfreundschuh Peter P. is a Chief Financial Officer at Voyager Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | VYGR Voyager Therapeutics, Inc. | Chief Financial Officer | Sell | 3,764 | $7.46 | $28,079.44 | -2.1% | +10.5% | -44.2% | |
| Oct 3, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Financial Officer | Sell | 13,567 | $6.99 | $94,833.33 | -8.3% | +27.7% | -17.4% | |
| Feb 22, 2022 | KRRO Korro Bio, Inc. | Chief Financial Officer | Sell | 2,946 | $3.69 | $10,885.03 | -13.2% | -62.9% | -80.4% | |
| Feb 17, 2022 | KRRO Korro Bio, Inc. | Chief Financial Officer | Sell | 2,525 | $4.31 | $10,886.44 | -9.2% | -70.0% | -83.5% | |
| Feb 15, 2022 | KRRO Korro Bio, Inc. | Chief Financial Officer | Sale+OE | 1,347 | $4.33 | $5,833.86 | -8.6% | -70.2% | -84.6% | |
| Oct 15, 2020 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 2,400 | $21.77 | $52,247.75 | -6.7% | - | - | |
| Sep 1, 2020 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 509 | $22.82 | $11,615.38 | -6.1% | - | - | |
| Jul 27, 2020 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 141 | $23.51 | $3,314.91 | -1.9% | - | - | |
| May 20, 2020 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 358 | $25.07 | $8,975.06 | -4.8% | - | - | |
| Apr 27, 2020 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 141 | $24.35 | $3,433.35 | -2.2% | - | - |